Yüklüyor......

Perspectives of U.S. Private Payers on Insurance Coverage for Pediatric and Prenatal Exome Sequencing – Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS)

PURPOSE: Exome sequencing (ES) has the potential to improve management of congenital anomalies and neurodevelopmental disorders in fetuses, infants and children. U.S. payers are key stakeholders in patient access to ES. We examined how payers view insurance coverage and clinical utility of pediatric...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Genet Med
Asıl Yazarlar: Trosman, Julia R., Weldon, Christine B., Slavotinek, Anne, Norton, Mary E., Douglas, Michael P., Phillips, Kathryn A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004856/
https://ncbi.nlm.nih.gov/pubmed/31501586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-019-0650-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!